
Advances in Autism 2017
Tamkin Auditorium
Ronald Reagan UCLA Medical Center
Los Angeles, California
April 28, 2017
Download: [ PDF ]
This full-day annual symposium is designed for all those interested in learning about the latest breakthroughs in research and treatment in autism spectrum disorder (ASD), including health care providers, teachers, autism service providers, and families. Nationally renowned UCLA Center for Autism Research and Treatment (CART) faculty, including Dr. Daniel Geschwind, Dr. Connie Kasari, and Dr. James McCracken, will present the most up-to-date information about ASD across the lifespan, from early markers, diagnosis, and neurobiology to both behavioral and pharmacological interventions in children and adults. The talks will combine clinical expertise with insights gained from research. This continuing education symposium is designed to equip community practitioners to apply the most effective “best practices” for assessment, management and treatment of individuals with ASD.
Target Audience
This full-day annual symposium is designed for all those interested in learning about the latest breakthroughs in research and treatment in autism spectrum disorder (ASD), including health care providers, teachers, autism service providers, and families.
Enrollment
Enrollment in this seminar is limited, so we suggest you enroll early.
Online
To enroll click here
By Mail
Send the completed enrollment form to:
David Geffen School of Medicine at UCLA
Office of Continuing Medical Education
Autism 2017
10920 Wilshire Blvd., Suite 1060
Los Angeles, CA 90024-6512
By FAX
Fax the enrollment form with charge card information and your authorizing signature to (310) 794-2624.
By Phone
Use your MasterCard, VISA, American Express or Discover. Call (310) 794-2620.
Registration Fee
- $195.00 Physicians
- $165.00 Nurses and Allied Health Professionals
- $90.00 Non-Healthcare Professionals
Refund
Cancellations must be received in writing by Friday, March 31, 2017 and will be subject to a $50 processing fee. No refunds will be granted after that date. If, for any reason, the course must be cancelled, discontinued, or rescheduled by the Office of Continuing Medical Education, a full refund will be provided.
Symposium Chair
Daniel H. Geschwind, MD, PhD
Gordon & Virginia MacDonald Distinguished Professor
Departments of Neurology, Psychiatry and Human Genetics*
Senior Associate Dean and Associate Vice Chancellor, Precision Health
Director, UCLA Center for Autism Research and Treatment (CART)
UCLA Course Faculty
Mirella Dapretto, PhD
Professor*
UCLA Department of Psychiatry and Biobehavioral Sciences
UCLA Center for Autism Research and Treatment
Amanda Gulsrud, PhD
Assistant Clinical Professor, Psychiatry & Biobehavioral Sciences*
Clinical Director, Child and Adult Neurodevelopmental (CAN) Clinic
Co-Investigator
UCLA Center for Autism Research and Treatment
Shafali Spurling Jeste, MD
Associate Professor of Psychiatry and Pediatrics*
Director, Developmental Neurophysiology Lab
UCLA Center for Autism Research and Treatment
Connie Kasari, PhD
Professor of Human Development and Psychology
Graduate School of Education and Information Studies
UCLA Department of Psychiatry*
UCLA Center for Autism Research & Treatment
Clara Lajonchere, PhD
Deputy Director, UCLA Institute for Precision Health
Elizabeth Laugeson, PsyD
Assistant Clinical Professor*
Founder and Director, UCLA PEERS Clinic
Director, The Help Group - UCLA Autism Research Alliance
Training Director, UCLA Tarjan Center UCEDD
James T. McCracken, MD
Joseph Campbell Professor of Child Psychiatry*
Director, Division of Child and Adolescent Psychiatry
UCLA Department of Psychiatry and Biobehavioral Sciences
UCLA Semel Institute
Principal Investigator and Director, Child and Adult Neurodevelopmental (CAN) Clinic
UCLA Center for Autism Research and Treatment
*David Geffen School of Medicine at UCLA
Friday, April 28, 2017 |
|
9:15 | Registration and Breakfast |
9:45 |
Welcome and Introduction Daniel H. Geschwind, MD, PhD |
10:00 |
Clinical Comorbidities in ASD: Diagnosis and Targeted Therapies Harley Kornblum, MD, PhD* |
10:45 |
The Quest for Early Markers of ASD: New Insight from Neuroimaging Mirella Dapretto, PhD |
11:30 |
Keynote Lecture Advances in the Genetics of Autism: Implications for Therapy Daniel H. Geschwind, MD, PhD |
12:15 | Lunch |
1:15 |
Early Childhood and ASD: Trajectories and Treatment Amanda Gulsrud, PhD |
1:45 |
Inclusion of Children with ASD Connie Kasari, PhD |
2:15 |
Big News in Drug Therapies for ASD James T. McCracken, MD |
2:45 | Break |
3:00 |
Improving Social Outcomes for Young Adults with ASD Elizabeth Laugeson, PsyD |
3:45 |
Changing the Landscape for Patients with Autism: Innovations in Digital Health Clara Lajonchere, PhD |
4:15 |
Ask the Expert Panel Facilitator: James T. McCracken, MD Panelists: Mirella Dapretto, PhD Shafali Spurling Jeste, MD Daniel H. Geschwind, MD, PhD Amanda Gulsrud, PhD Connie Kasari, PhD James T. McCracken, MD Elizabeth Laugeson, PsyD Clara Lajonchere, PhD |
5:00 |
Closing Remarks Daniel H. Geschwind, MD, PhD |
5:10 | Adjourn |
*UCLA Course Faculty Update
At the conclusion of this course, participants should be able to:
- Update practitioners in psychiatry, psychology, primary care, and other health professions, as well as teachers and autism service providers, on the state-of-the-art scientific findings for understanding, identifying, evaluating and treating autism spectrum disorders (ASD) across the lifespan
- Understand the latest developments about genetics, neurobiology, behavioral health and clinical factors, biomarkers for early identification and early diagnosis, and innovative treatment models that can benefit infants, children and young adults with ASD
- Understand best practices for clinical care of individuals with ASD at various developmental stages, specifically in terms of early identification, diagnostic evaluation and treatment planning
- Review recent research findings from studies on genetics, brain imaging (connectivity and reward circuits), epidemiology and environmental factors, and psychopharmacology for understanding and developing treatments regarding specific brain systems disrupted in ASD
The Office of Continuing Medical Education, David Geffen School of Medicine at UCLA is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
The Office of Continuing Medical Education, David Geffen School of Medicine at UCLA designates this live activity for a maximum of 6 AMA PRA Category 1 Credits TM. Physicians should claim only credit commensurate with the extent of their participation in the activity.
The FDA has issued a concept paper which classifies commercial support of scientific and educational programs as promotional unless it can be affirmed that the program is "truly independent" and free of commercial influence. In addition to independence, the FDA requires that nonpromotional, commercially supported education be objective, balanced, and scientifically rigorous. The policy further states that all potential conflicts of interest of the CME staff and faculty be fully disclosed to the program's participants. In addition, Accreditation Council for Continuing Medical Education policy now mandates that the provider adequately manages all identified potential conflicts of interest prior to the program. We at UCLA fully endorse the letter and spirit of these concepts.
Program Location
Tamkin Auditorium
Ronald Reagan UCLA Medical Center
757 Westwood Plaza
Los Angeles, CA 90095
Directions and Parking
From the 405 freeway, exit Wilshire Blvd., east toward Westwood. Turn left on Westwood Blvd., travel past Charles E. Young Dr. South and turn left on Structure 8 driveway. Drive up the ramp to the rooftop level to park. Pay per license plate at the kiosk and display the parking permit on your dash. All day parking is $12.00. The Ronald Reagan UCLA Medical Center is located on the corner of Westwood Plaza and Charles E. Young Dr. South.